No profile data available.
Agilent Technologies, Inc. (A) is a healthcare company in the biological analysis equipment industry, based in Santa Clara, United States, with about 18,000 full-time employees.
It reported revenue of $6.95 billion for fiscal year 2025, and net income of $1.30 billion. In Q3 2026 (the quarter ended July 31, 2026) revenue was $1.88 billion. Its largest business segment, Agilent Crosslab Segment, brought in 42% of segment revenue in fiscal year 2025; Rest of the World was the largest region with 49%. Its market capitalization was $42.05 billion as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended October 31, 2025; market data as of December 4, 2025.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab.
Agilent Technologies reported $6.95 billion in revenue for fiscal year 2025. In Q3 2026 revenue was $1.88 billion.
Agilent Crosslab Segment, with $2.91 billion or 42% of segment revenue in fiscal year 2025. Next: Life Sciences and Diagnostics Markets Segment (39%) and Applied Markets Segment (19%).
Rest of the World: 49% of revenue by region in fiscal year 2025, followed by United States (34%).
$42.05 billion as of December 4, 2025.
Listed companies of a similar size in the same industry (biological analysis equipment) include Danaher Corporation (DHR), Illumina, Inc. (ILMN), Mettler-Toledo International Inc. (MTD), Revvity, Inc. (RVTY).